[Primary plasma cell leukemia (IgD-lambda) with hyperammonemia].
D000641:Ammonia / Q000097:blood; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D022124:Hyperammonemia / Q000209:etiology*; D007072:Immunoglobulin D / Q000032:analysis; D007952:Leukemia, Plasma Cell / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D014408:Biomarkers, Tumor; D007072:Immunoglobulin D; D014750:Vincristine; D000641:Ammonia; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide